|
Hi,
Policy deadlines, affordability pressures, and rising patient expectations have converged to make direct-to-patient access an executive-level priority. The question is no longer if, but how.
Successful DTP programs require a new approach—one that prioritizes affordability, convenience, and commercial viability. The next generation of DTP needs to integrate services like telemedicine, fulfillment, and patient support into a single, seamless experience that reflects today’s patients’ modern e-commerce standards. The goal is to reduce friction and help more patients start and stay on therapy, easily and affordably.
Our thought leadership piece was recently shared in Life Science Leader, "Pharma Direct-To-Patient 2.0: From Experiment To Imperative," where our CEO & Founder, Deepak Thomas, explores how leading companies are turning DTP into a scalable, compliant, and commercially sustainable strategy.
If you're ready to explore how we can help your brands enter the new era of DTP success, learn more at www.phildtup.us.
|
